Review
Published on 12 Sep 2022
Role of autophagy in tumor response to radiation: Implications for improving radiotherapy
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.957373
- 4,323 views
- 10 citations
Type at least 3 characters
1,766 articles
Articles
Case Report
Published on 08 Sep 2022
Transformation of adenocarcinoma to squamous cell carcinoma as a source of EGFR-TKI resistance: A case report and literature review
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.942084
- 2,040 views
- 2 citations
Original Research
Published on 08 Sep 2022
Analysis of the prognostic, diagnostic and immunological role of HSP90α in malignant tumors
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.963719
- 2,971 views
- 8 citations
Review
Published on 07 Sep 2022
Bacteria-derived chimeric toxins as potential anticancer agents
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.953678
- 4,751 views
- 9 citations
Brief Research Report
Published on 06 Sep 2022
Next-generation sequencing based detection of BRCA1 and BRCA2 large genomic rearrangements in Chinese cancer patients
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.898916
- 4,384 views
- 2 citations
Mini Review
Published on 02 Sep 2022
Beyond targeting amplified MDM2 and CDK4 in well differentiated and dedifferentiated liposarcomas: From promise and clinical applications towards identification of progression drivers
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.965261
- 3,794 views
- 8 citations
Mini Review
Published on 02 Sep 2022
Berberine as a potential agent for breast cancer therapy
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.993775
- 12,550 views
- 29 citations
Review
Published on 02 Sep 2022
The research progress of targeted therapy in acute myeloid leukemia based on bibliometric analysis
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.957370
- 3,560 views
- 1 citation
Original Research
Published on 31 Aug 2022
Expression and prognosis analysis of PAQR5 in kidney cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.955510
- 4,201 views
- 2 citations
Review
Published on 31 Aug 2022
An overview of agents and treatments for PDGFRA-mutated gastrointestinal stromal tumors
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.927587
- 11,738 views
- 17 citations
Original Research
Published on 30 Aug 2022
Endocytosis of the thrombopoietin receptor Mpl regulates megakaryocyte and erythroid maturation in mice
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.959806
- 4,003 views
- 3 citations
Original Research
Published on 26 Aug 2022
Pediatric glioblastoma cells are sensitive to drugs that inhibit eIF2α dephosphorylation and its phosphomimetic S51D variant
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.959133
- 2,741 views
- 1 citation
Original Research
Published on 25 Aug 2022
Design, synthesis, and anticancer activity of three novel palbociclib derivatives
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.959322
- 2,654 views
- 2 citations
Mini Review
Published on 24 Aug 2022
The history of small extracellular vesicles and their implication in cancer drug resistance
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.948843
- 3,768 views
- 12 citations
Case Report
Published on 24 Aug 2022
Sirolimus combined with interferon-alpha 2b therapy for giant hepatic epithelioid hemangioendothelioma: a case report
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.972306
- 1,813 views
- 4 citations
Mini Review
Published on 24 Aug 2022
Precision oncology for RET-related tumors
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.992636
- 6,166 views
- 12 citations